1 Nucleic Vaccine Market Overview 1.1 Nucleic Vaccine Product Overview 1.2 Nucleic Vaccine Market Segment by Type 1.2.1 Preventive Nucleic Vaccine 1.2.2 Therapeutic Nucleic Vaccine 1.3 Global Nucleic Vaccine Market Size by Type 1.3.1 Global Nucleic Vaccine Market Size Overview by Type (2016-2027) 1.3.2 Global Nucleic Vaccine Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Nucleic Vaccine Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Nucleic Vaccine Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Nucleic Vaccine Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Nucleic Vaccine Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Nucleic Vaccine Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Nucleic Vaccine Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Nucleic Vaccine Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Nucleic Vaccine Sales Breakdown by Type (2016-2021) 1.4.2 Europe Nucleic Vaccine Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Nucleic Vaccine Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Nucleic Vaccine Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Nucleic Vaccine Sales Breakdown by Type (2016-2021) 2 Global Nucleic Vaccine Market Competition by Company 2.1 Global Top Players by Nucleic Vaccine Sales (2016-2021) 2.2 Global Top Players by Nucleic Vaccine Revenue (2016-2021) 2.3 Global Top Players Nucleic Vaccine Price (2016-2021) 2.4 Global Top Manufacturers Nucleic Vaccine Manufacturing Base Distribution, Sales Area, Product Type 2.5 Nucleic Vaccine Market Competitive Situation and Trends 2.5.1 Nucleic Vaccine Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Nucleic Vaccine Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nucleic Vaccine as of 2020) 2.7 Date of Key Manufacturers Enter into Nucleic Vaccine Market 2.8 Key Manufacturers Nucleic Vaccine Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Nucleic Vaccine Status and Outlook by Region 3.1 Global Nucleic Vaccine Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Nucleic Vaccine Historic Market Size by Region 3.2.1 Global Nucleic Vaccine Sales in Volume by Region (2016-2021) 3.2.2 Global Nucleic Vaccine Sales in Value by Region (2016-2021) 3.2.3 Global Nucleic Vaccine Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Nucleic Vaccine Forecasted Market Size by Region 3.3.1 Global Nucleic Vaccine Sales in Volume by Region (2022-2027) 3.3.2 Global Nucleic Vaccine Sales in Value by Region (2022-2027) 3.3.3 Global Nucleic Vaccine Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Nucleic Vaccine by Application 4.1 Nucleic Vaccine Market Segment by Application 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Others 4.2 Global Nucleic Vaccine Market Size by Application 4.2.1 Global Nucleic Vaccine Market Size Overview by Application (2016-2027) 4.2.2 Global Nucleic Vaccine Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Nucleic Vaccine Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Nucleic Vaccine Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Nucleic Vaccine Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Nucleic Vaccine Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Nucleic Vaccine Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Nucleic Vaccine Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Nucleic Vaccine Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Nucleic Vaccine Sales Breakdown by Application (2016-2021) 4.3.2 Europe Nucleic Vaccine Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Nucleic Vaccine Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Nucleic Vaccine Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Nucleic Vaccine Sales Breakdown by Application (2016-2021) 5 North America Nucleic Vaccine by Country 5.1 North America Nucleic Vaccine Historic Market Size by Country 5.1.1 North America Nucleic Vaccine Sales in Volume by Country (2016-2021) 5.1.2 North America Nucleic Vaccine Sales in Value by Country (2016-2021) 5.2 North America Nucleic Vaccine Forecasted Market Size by Country 5.2.1 North America Nucleic Vaccine Sales in Volume by Country (2022-2027) 5.2.2 North America Nucleic Vaccine Sales in Value by Country (2022-2027) 6 Europe Nucleic Vaccine by Country 6.1 Europe Nucleic Vaccine Historic Market Size by Country 6.1.1 Europe Nucleic Vaccine Sales in Volume by Country (2016-2021) 6.1.2 Europe Nucleic Vaccine Sales in Value by Country (2016-2021) 6.2 Europe Nucleic Vaccine Forecasted Market Size by Country 6.2.1 Europe Nucleic Vaccine Sales in Volume by Country (2022-2027) 6.2.2 Europe Nucleic Vaccine Sales in Value by Country (2022-2027) 7 Asia-Pacific Nucleic Vaccine by Region 7.1 Asia-Pacific Nucleic Vaccine Historic Market Size by Region 7.1.1 Asia-Pacific Nucleic Vaccine Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Nucleic Vaccine Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Nucleic Vaccine Forecasted Market Size by Region 7.2.1 Asia-Pacific Nucleic Vaccine Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Nucleic Vaccine Sales in Value by Region (2022-2027) 8 Latin America Nucleic Vaccine by Country 8.1 Latin America Nucleic Vaccine Historic Market Size by Country 8.1.1 Latin America Nucleic Vaccine Sales in Volume by Country (2016-2021) 8.1.2 Latin America Nucleic Vaccine Sales in Value by Country (2016-2021) 8.2 Latin America Nucleic Vaccine Forecasted Market Size by Country 8.2.1 Latin America Nucleic Vaccine Sales in Volume by Country (2022-2027) 8.2.2 Latin America Nucleic Vaccine Sales in Value by Country (2022-2027) 9 Middle East and Africa Nucleic Vaccine by Country 9.1 Middle East and Africa Nucleic Vaccine Historic Market Size by Country 9.1.1 Middle East and Africa Nucleic Vaccine Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Nucleic Vaccine Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Nucleic Vaccine Forecasted Market Size by Country 9.2.1 Middle East and Africa Nucleic Vaccine Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Nucleic Vaccine Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Nucleic Vaccine Business 10.1 Moderna 10.1.1 Moderna Corporation Information 10.1.2 Moderna Introduction and Business Overview 10.1.3 Moderna Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Moderna Nucleic Vaccine Products Offered 10.1.5 Moderna Recent Development 10.2 CureVac 10.2.1 CureVac Corporation Information 10.2.2 CureVac Introduction and Business Overview 10.2.3 CureVac Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Moderna Nucleic Vaccine Products Offered 10.2.5 CureVac Recent Development 10.3 Inovio 10.3.1 Inovio Corporation Information 10.3.2 Inovio Introduction and Business Overview 10.3.3 Inovio Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Inovio Nucleic Vaccine Products Offered 10.3.5 Inovio Recent Development 10.4 Sanofi 10.4.1 Sanofi Corporation Information 10.4.2 Sanofi Introduction and Business Overview 10.4.3 Sanofi Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Sanofi Nucleic Vaccine Products Offered 10.4.5 Sanofi Recent Development 10.5 GSK 10.5.1 GSK Corporation Information 10.5.2 GSK Introduction and Business Overview 10.5.3 GSK Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.5.4 GSK Nucleic Vaccine Products Offered 10.5.5 GSK Recent Development 10.6 CNBG 10.6.1 CNBG Corporation Information 10.6.2 CNBG Introduction and Business Overview 10.6.3 CNBG Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.6.4 CNBG Nucleic Vaccine Products Offered 10.6.5 CNBG Recent Development 10.7 Hualan Bio 10.7.1 Hualan Bio Corporation Information 10.7.2 Hualan Bio Introduction and Business Overview 10.7.3 Hualan Bio Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Hualan Bio Nucleic Vaccine Products Offered 10.7.5 Hualan Bio Recent Development 10.8 Zhifei Shengwu 10.8.1 Zhifei Shengwu Corporation Information 10.8.2 Zhifei Shengwu Introduction and Business Overview 10.8.3 Zhifei Shengwu Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Zhifei Shengwu Nucleic Vaccine Products Offered 10.8.5 Zhifei Shengwu Recent Development 10.9 Liaoning Chengda 10.9.1 Liaoning Chengda Corporation Information 10.9.2 Liaoning Chengda Introduction and Business Overview 10.9.3 Liaoning Chengda Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Liaoning Chengda Nucleic Vaccine Products Offered 10.9.5 Liaoning Chengda Recent Development 10.10 BioKangtai 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Nucleic Vaccine Product Category, Application and Specification 10.10.3 BioKangtai Nucleic Vaccine Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 BioKangtai Recent Development 10.11 CanSinoBIO 10.11.1 CanSinoBIO Corporation Information 10.11.2 CanSinoBIO Introduction and Business Overview 10.11.3 CanSinoBIO Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.11.4 CanSinoBIO Nucleic Vaccine Products Offered 10.11.5 CanSinoBIO Recent Development 10.12 Walvax Biotechnology 10.12.1 Walvax Biotechnology Corporation Information 10.12.2 Walvax Biotechnology Introduction and Business Overview 10.12.3 Walvax Biotechnology Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.12.4 Walvax Biotechnology Nucleic Vaccine Products Offered 10.12.5 Walvax Biotechnology Recent Development 10.13 Fosun Pharma 10.13.1 Fosun Pharma Corporation Information 10.13.2 Fosun Pharma Introduction and Business Overview 10.13.3 Fosun Pharma Nucleic Vaccine Sales, Revenue and Gross Margin (2016-2021) 10.13.4 Fosun Pharma Nucleic Vaccine Products Offered 10.13.5 Fosun Pharma Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Nucleic Vaccine Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Nucleic Vaccine Industrial Chain Analysis 11.4 Nucleic Vaccine Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Nucleic Vaccine Distributors 12.3 Nucleic Vaccine Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Preventive Nucleic Vaccine Table 2. Major Company of Therapeutic Nucleic Vaccine Table 3. Global Nucleic Vaccine Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Nucleic Vaccine Sales by Type (2016-2021) & (K Units) Table 5. Global Nucleic Vaccine Sales Market Share in Volume by Type (2016-2021) Table 6. Global Nucleic Vaccine Sales by Type (2016-2021) & (US& Million) Table 7. Global Nucleic Vaccine Market Share in Value by Type (2016-2021) Table 8. Global Nucleic Vaccine Price by Type (2016-2021) & (US$/Unit) Table 9. Global Nucleic Vaccine Sales by Type (2022-2027) & (K Units) Table 10. Global Nucleic Vaccine Sales Market Share in Volume by Type (2022-2027) Table 11. Global Nucleic Vaccine Sales by Type (2022-2027) & (US$ Million) Table 12. Global Nucleic Vaccine Sales Market Share in Value by Type (2022-2027) Table 13. Global Nucleic Vaccine Price by Type (2022-2027) & (US$/Unit) Table 14. North America Nucleic Vaccine Sales by Type (2016-2021) & (K Units) Table 15. North America Nucleic Vaccine Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Nucleic Vaccine Sales (K Units) by Type (2016-2021) Table 17. Europe Nucleic Vaccine Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Nucleic Vaccine Sales (K Units) by Type (2016-2021) Table 19. Asia-Pacific Nucleic Vaccine Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Nucleic Vaccine Sales (K Units) by Type (2016-2021) Table 21. Latin America Nucleic Vaccine Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Nucleic Vaccine Sales (K Units) by Type (2016-2021) Table 23. Middle East and Africa Nucleic Vaccine Sales by Type (2016-2021) & (US$ Million) Table 24. Global Nucleic Vaccine Sales by Company (2016-2021) & (K Units) Table 25. Global Nucleic Vaccine Sales Share by Company (2016-2021) Table 26. Global Nucleic Vaccine Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Nucleic Vaccine Revenue Share by Company (2016-2021) Table 28. Global Market Nucleic Vaccine Price by Company (2016-2021) & (US$/Unit) Table 29. Global Nucleic Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Nucleic Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nucleic Vaccine as of 2020 Table 32. Date of Key Manufacturers Enter into Nucleic Vaccine Market Table 33. Key Manufacturers Nucleic Vaccine Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Nucleic Vaccine Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Nucleic Vaccine Sales by Region (2016-2021) & (K Units) Table 37. Global Nucleic Vaccine Sales Market Share in Volume by Region (2016-2021) Table 38. Global Nucleic Vaccine Sales by Region (2016-2021) & (US$ Million) Table 39. Global Nucleic Vaccine Sales Market Share in Value by Region (2016-2021) Table 40. Global Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 41. Global Nucleic Vaccine Sales by Region (2022-2027) & (K Units) Table 42. Global Nucleic Vaccine Sales Market Share in Volume by Region (2022-2027) Table 43. Global Nucleic Vaccine Sales by Region (2022-2027) & (US$ Million) Table 44. Global Nucleic Vaccine Sales Market Share in Value by Region (2022-2027) Table 45. Global Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027) Table 46. Global Nucleic Vaccine Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Nucleic Vaccine Sales by Application (2016-2021) & (K Units) Table 48. Global Nucleic Vaccine Sales Market Share in Volume by Application (2016-2021) Table 49. Global Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million) Table 50. Global Nucleic Vaccine Sales Market Share in Value by Application (2016-2021) Table 51. Global Nucleic Vaccine Price by Application (2016-2021) & (US$/Unit) Table 52. Global Nucleic Vaccine Sales by Application (2022-2027) & (K Units) Table 53. Global Nucleic Vaccine Sales Market Share in Volume by Application (2022-2027) Table 54. Global Nucleic Vaccine Sales by Application (2022-2027) & (US$ Million) Table 55. Global Nucleic Vaccine Sales Market Share in Value by Application (2022-2027) Table 56. Global Nucleic Vaccine Price by Application (2022-2027) & (US$/Unit) Table 57. North America Nucleic Vaccine Sales by Application (2016-2021) (K Units) Table 58. North America Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million) Table 59. North America Nucleic Vaccine Sales Market Share in Value by Application in 2020 Table 60. Europe Nucleic Vaccine Sales by Application (2016-2021) (K Units) Table 61. Europe Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Nucleic Vaccine Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Nucleic Vaccine Sales by Application (2016-2021) (K Units) Table 64. Asia-Pacific Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Application in 2020 Table 66. Latin America Nucleic Vaccine Sales by Application (2016-2021) (K Units) Table 67. Latin America Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Nucleic Vaccine Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Nucleic Vaccine Sales by Application (2016-2021) (K Units) Table 70. Middle East and Africa Nucleic Vaccine Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Application in 2020 Table 72. North America Nucleic Vaccine Sales by Country (2016-2021) & (K Units) Table 73. North America Nucleic Vaccine Sales Market Share in Volume by Country (2016-2021) Table 74. North America Nucleic Vaccine Sales by Country (2016-2021) & (US$ Million) Table 75. North America Nucleic Vaccine Sales Market Share in Value by Country (2016-2021) Table 76. North America Nucleic Vaccine Sales by Country (2022-2027) & (K Units) Table 77. North America Nucleic Vaccine Sales Market Share in Volume by Country (2022-2027) Table 78. North America Nucleic Vaccine Sales by Country (2022-2027) & (US$ Million) Table 79. North America Nucleic Vaccine Sales Market Share in Value by Country (2022-2027) Table 80. Europe Nucleic Vaccine Sales by Country (2016-2021) & (K Units) Table 81. Europe Nucleic Vaccine Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Nucleic Vaccine Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Nucleic Vaccine Sales Market Share in Value by Country (2016-2021) Table 84. Europe Nucleic Vaccine Sales by Country (2022-2027) & (K Units) Table 85. Europe Nucleic Vaccine Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Nucleic Vaccine Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Nucleic Vaccine Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Nucleic Vaccine Sales by Region (2016-2021) & (K Units) Table 89. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Nucleic Vaccine Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Nucleic Vaccine Sales by Region (2022-2027) & (K Units) Table 93. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Nucleic Vaccine Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Nucleic Vaccine Sales by Country (2016-2021) & (K Units) Table 97. Latin America Nucleic Vaccine Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Nucleic Vaccine Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Nucleic Vaccine Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Nucleic Vaccine Sales by Country (2022-2027) & (K Units) Table 101. Latin America Nucleic Vaccine Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Nucleic Vaccine Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Nucleic Vaccine Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Nucleic Vaccine Sales by Country (2016-2021) & (K Units) Table 105. Middle East and Africa Nucleic Vaccine Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Nucleic Vaccine Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Nucleic Vaccine Sales by Country (2022-2027) & (K Units) Table 109. Middle East and Africa Nucleic Vaccine Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Nucleic Vaccine Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Country (2022-2027) Table 112. Moderna Corporation Information Table 113. Moderna Introduction and Business Overview Table 114. Moderna Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 115. Moderna Nucleic Vaccine Product Table 116. Moderna Recent Development Table 117. CureVac Corporation Information Table 118. CureVac Introduction and Business Overview Table 119. CureVac Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 120. CureVac Nucleic Vaccine Product Table 121. CureVac Recent Development Table 122. Inovio Corporation Information Table 123. Inovio Introduction and Business Overview Table 124. Inovio Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 125. Inovio Nucleic Vaccine Product Table 126. Inovio Recent Development Table 127. Sanofi Corporation Information Table 128. Sanofi Introduction and Business Overview Table 129. Sanofi Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 130. Sanofi Nucleic Vaccine Product Table 131. Sanofi Recent Development Table 132. GSK Corporation Information Table 133. GSK Introduction and Business Overview Table 134. GSK Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 135. GSK Nucleic Vaccine Product Table 136. GSK Recent Development Table 137. CNBG Corporation Information Table 138. CNBG Introduction and Business Overview Table 139. CNBG Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 140. CNBG Nucleic Vaccine Product Table 141. CNBG Recent Development Table 142. Hualan Bio Corporation Information Table 143. Hualan Bio Introduction and Business Overview Table 144. Hualan Bio Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 145. Hualan Bio Nucleic Vaccine Product Table 146. Hualan Bio Recent Development Table 147. Zhifei Shengwu Corporation Information Table 148. Zhifei Shengwu Introduction and Business Overview Table 149. Zhifei Shengwu Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 150. Zhifei Shengwu Nucleic Vaccine Product Table 151. Zhifei Shengwu Recent Development Table 152. Liaoning Chengda Corporation Information Table 153. Liaoning Chengda Introduction and Business Overview Table 154. Liaoning Chengda Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 155. Liaoning Chengda Nucleic Vaccine Product Table 156. Liaoning Chengda Recent Development Table 157. BioKangtai Corporation Information Table 158. BioKangtai Introduction and Business Overview Table 159. BioKangtai Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 160. BioKangtai Nucleic Vaccine Product Table 161. BioKangtai Recent Development Table 162. CanSinoBIO Corporation Information Table 163. CanSinoBIO Introduction and Business Overview Table 164. CanSinoBIO Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 165. CanSinoBIO Nucleic Vaccine Product Table 166. CanSinoBIO Recent Development Table 167. Walvax Biotechnology Corporation Information Table 168. Walvax Biotechnology Introduction and Business Overview Table 169. Walvax Biotechnology Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 170. Walvax Biotechnology Nucleic Vaccine Product Table 171. Walvax Biotechnology Recent Development Table 172. Fosun Pharma Corporation Information Table 173. Fosun Pharma Introduction and Business Overview Table 174. Fosun Pharma Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 175. Fosun Pharma Nucleic Vaccine Product Table 176. Fosun Pharma Recent Development Table 177. Key Raw Materials Lists Table 178. Raw Materials Key Suppliers Lists Table 179. Nucleic Vaccine Market Trends Table 180. Nucleic Vaccine Market Drivers Table 181. Nucleic Vaccine Market Challenges Table 182. Nucleic Vaccine Market Restraints Table 183. Nucleic Vaccine Distributors List Table 184. Nucleic Vaccine Downstream Customers Table 185. Research Programs/Design for This Report Table 186. Key Data Information from Secondary Sources Table 187. Key Data Information from Primary Sources List of Figures Figure 1. Nucleic Vaccine Product Picture Figure 2. Global Nucleic Vaccine Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Nucleic Vaccine Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Nucleic Vaccine Sales Status and Outlook (2016-2027) & (K Units) Figure 5. Product Picture of Preventive Nucleic Vaccine Figure 6. Global Preventive Nucleic Vaccine Sales YoY Growth (2016-2021) & (K Units) Figure 7. Product Picture of Therapeutic Nucleic Vaccine Figure 8. Global Therapeutic Nucleic Vaccine Sales YoY Growth (2016-2021) & (K Units) Figure 9. Global Nucleic Vaccine Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Nucleic Vaccine Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Nucleic Vaccine Sales Market Share in Value by Type (2016-2021) Figure 12. Global Nucleic Vaccine Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Nucleic Vaccine Sales Market Share in Value by Type (2022-2027) Figure 14. North America Nucleic Vaccine Sales Market Share in Volume by Type in 2020 Figure 15. North America Nucleic Vaccine Sales Market Share in Value by Type in 2020 Figure 16. Europe Nucleic Vaccine Sales Market Share in Volume by Type in 2020 Figure 17. Europe Nucleic Vaccine Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Type in 2020 Figure 20. Latin America Nucleic Vaccine Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Nucleic Vaccine Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Nucleic Vaccine Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Nucleic Vaccine Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Nucleic Vaccine Revenue in 2020 Figure 26. Nucleic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Hospital Figure 28. Global Hospital Sales YoY Growth (2016-2027) & (K Units) Figure 29. Product Picture of Clinic Figure 30. Global Clinic Sales YoY Growth (2016-2027) & (K Units) Figure 31. Product Picture of Others Figure 32. Global Others Sales YoY Growth (2016-2027) & (K Units) Figure 33. Global Nucleic Vaccine Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Nucleic Vaccine Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Nucleic Vaccine Sales Market Share in Value by Application (2016-2021) Figure 36. Global Nucleic Vaccine Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Nucleic Vaccine Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Nucleic Vaccine Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Nucleic Vaccine Manufacturing Cost Structure Figure 42. Nucleic Vaccine Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Moderna CureVac Inovio Sanofi GSK CNBG Hualan Bio Zhifei Shengwu Liaoning Chengda BioKangtai CanSinoBIO Walvax Biotechnology Fosun Pharma